Ligand-Based Technologies Integrated into Flare™ V5 Offer a Comprehensive Molecule Design Solution for Drug Discovery Research Chemists

Cresset, innovative provider of outstanding software for molecule discovery and design, announces the release of Flare V5, its comprehensive molecule design platform.

Flare enables research chemists to discover novel small molecules more efficiently and effectively in a single platform. Image Credit: Cresset

This release of Flare incorporates the advanced ligand-based methods validated through years of use in Forge™ with its established structure-based science. The integration enables chemists to discover novel molecules more efficiently and effectively. Significant enhancements have also been made to increase the speed and automation of Free Energy Perturbation (FEP) calculations, enabling single compounds to be predicted in as little as 30 minutes. New analysis methods have been added to help understand the behavior of water within the target active site.
 
“Flare has evolved from a structure-based design tool” says Dr Giovanna Tedesco, Head of Products. “In this exciting development, ligand and structure-based methods work in full synergy, allowing medicinal and computational chemists to access Cresset intuitive science in a single platform to advance their drug discovery projects.”
 
“Flare V5 also features new and enhanced science, and improvements to the GUI to increase usability. We now offer a comprehensive solution to streamline molecule design and the prioritization of new molecules for synthesis.”

Source: https://www.cresset-group.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.